Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1753 of 6351
-
Vaccine aims to outsmart drug resistance in ALK-Positive lung cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety of a cancer peptide vaccine to prevent or delay acquired resistance in advanced ALK+ lung cancer patients currently on ALK targeted therapy.
Phase 1/2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Should all advanced lung cancer patients get a brain scan? new trial aims to find out
Diagnosis Recruiting nowPatients with newly diagnosed stage IV non-oncogene addicted NSCLC, who are fit for systemic treatment and don't have any symptoms of brain disease will undergo an MRI of the brain to screen for brain disease.
Sponsor: University Medical Center Groningen • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Peer support trial aims to ease the heavy burden on lewy body dementia caregivers
Symptom relief OngoingLewy Body Dementia (LBD) is the second most common form of degenerative dementia, affecting at least 2.4 million US adults, and the overwhelming majority of persons living with LBD (PLBD) are cared for by family caregivers. LBD caregiver strain: 1) exceeds that of non-LBD dementi…
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can we stop this arthritis drug without relapse? new trial aims to find out
Disease control OngoingGiant cell arteritis (GCA) is a large-vessel vasculitis that typically occurs in people over the age of 50. Corticosteroids (GC) are the cornerstone of treatment for GCA. French guidelines recommend starting at 0.7 or 1 mg/kg/day at diagnosis, depending on the occurence of ische…
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Patient's own immune cells take on head and neck cancer in new trial
Disease control Recruiting nowThis study is a single-arm early exploratory clinical study. designed to evaluate the safety and tolerability of GT201 in combination with a PD-1 inhibitor for the treatment of advanced head and neck tumor subjects with safety and tolerability, as well as pharmacokinetic characte…
Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a simple breath test spot liver cirrhosis early?
Diagnosis CompletedOwlstone Medical has demonstrated that the use of an Exogenous Volatile Organic Compound (EVOC) that targets specific metabolic processes linked to cirrhosis pathophysiology enables identification of subjects with cirrhosis with high accuracy compared to healthy controls. This ap…
Sponsor: Owlstone Ltd • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Could a synthetic DMT analog ease severe anxiety? small trial begins
Symptom relief CompletedThe purpose of this proof-of-concept trial is to examine the safety, tolerability, and pharmacokinetics (PK), and preliminary clinical efficacy of CYB004 participants with GAD.
Phase 2 • Sponsor: Cybin IRL Limited • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can mindfulness or CBT fix insomnia after a concussion?
Symptom relief Recruiting nowThis study is a prospective two-arm, single blind randomized controlled trial design to compare the clinical effectiveness of telemedicine-delivered, 6-session, standardized cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based treatment for insomnia (MBTI) in t…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Magnetic bypass: a new tool against obesity and diabetes?
Disease control OngoingThe objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel c…
Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a new drug calm irritability in kids with autism?
Symptom relief CompletedStudy ITI-007-035 is a Phase 1b, multicenter, open-label study to evaluate the safety, tolerability, and PK of lumateperone for pediatric patients with Autism Spectrum Disorder.
Phase 1 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Bringing the hospital home: a new model for End-Stage liver care
Disease control Recruiting nowThe purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based car…
Sponsor: Indiana University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New pill aims to boost immune attack on Hard-to-Treat cancers
Disease control Recruiting nowGIM-531 is a first-in-class, orally bioavailable small molecule that is being developed for the treatment of advanced solid tumors as a single agent and rescue therapy. GIM-531 exhibits its primary effect through selective inhibition of regulatory T-cells (Tregs).
Phase 1/2 • Sponsor: Georgiamune Inc • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can targeted neck exercises outperform standard stretching?
Symptom relief CompletedThis trial compared eccentric exercise training and the proprioceptive neuromuscular facilitation (PNF) technique, each added to a common cervical stretching and stabilisation programme, in individuals with non-specific neck pain. Outcomes were neck-related disability, multidimen…
Sponsor: Uskudar University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Sound waves aim to quiet opioid cravings
Disease control Recruiting nowThis is a randomized, double-blind, sham-controlled, partial crossover study investigating LIFU targeting the NAc and VC for participants with severe, treatment refractory OUD.
Sponsor: Ali Rezai • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a lupus drug shield organs from Long-Term harm?
Disease control CompletedThis is an External control arm study to generate evidence on the comparative effect of anifrolumab plus Standard of Care in TULIP versus Real World Standard of Care on organ damage in adult patients with moderately to severely active Systemic lupus erythematosus (SLE). Patients …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New daily pill could cut migraine days in half
Disease control OngoingThe purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of atogepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can dermal fillers reveal the secrets of skin aging?
Knowledge-focused OngoingThe purpose of the study is to investigate the impact of the injection of dermal filler on the quality of the skin dermal extracellular matrix in persons between the ages of 30-50 years. The quality of the dermal extracellular matrix will be assessed following injection of dermal…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
A 12-minute video could save new mothers' lives – can it teach them to spot danger?
Knowledge-focused Stopped earlyThis is a prospective, single-center, randomized control study to determine if video education at the time of postpartum discharge improves patient knowledge on the warning signs for the top three causes of severe maternal morbidity (infection, hemorrhage, and blood pressure diso…
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
New study checks if etrasimod tames ulcerative colitis symptoms in daily life
Disease control OngoingThe purpose of this real world non-interventional study is to learn about the effects of etrasimod as treatment for patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is …
Sponsor: Pfizer • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for bile duct cancer: experimental combo targets tough tumors
Disease control Recruiting nowBackground: Biliary tract carcinoma (BTC) is cancer of the slender tubes that carry fluids in the liver. People with advanced BTC have few treatment options, and their survival rates are very low. Objective: To test a study drug (CDX-1140) combined 3 other drugs (capecitabine,…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC